SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-23-057268
Filing Date
2023-03-02
Accepted
2023-03-02 07:24:07
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 d461492d424b5.htm 424B5 8483
2 GRAPHIC g461492g01a01.jpg GRAPHIC 55112
3 GRAPHIC g461492g02a02.jpg GRAPHIC 26667
  Complete submission text file 0001193125-23-057268.txt   119462
Mailing Address 805 LAS CIMAS PARKWAY SUITE 100 AUSTIN TX 78746
Business Address 805 LAS CIMAS PARKWAY SUITE 100 AUSTIN TX 78746 (512) 942-2935
Aeglea BioTherapeutics, Inc. (Filer) CIK: 0001636282 (see all company filings)

IRS No.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-239706 | Film No.: 23696410
SIC: 2834 Pharmaceutical Preparations